Pharmacy Daily | New diabetes drink

Patented food-grade pre-meal drink GlucoSmooth by Omniblend Innovation, for managing type 2 diabetes (T2D), is planned to be on pharmacy shelves early next year, following an announcement from EVE Investments. The company says it has entered into a binding agreement to acquire a 40% stake in Omniblend Innovation, a medical technology company focused on foods for special medical purposes. According to the announcement, the product has been clinically shown to reduce blood glucose level peaks by 35% after carbohydrate containing meals. EVE Innovations has also announced that it has an exclusive six-year national distribution agreement in place to bring GlucoSmooth to more than 6,000 pharmacy shelves in Australia and New Zealand by mid 2016. Australia is estimated to have over three million people with T2D or pre-diabetes, that figure growing around 3% per year, making it one of Australia’s fastest growing chronic diseases.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 21 Dec 15
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Dec 15